| dbo:abstract
|
- COVID-19 vaccination in Sri Lanka is an ongoing immunisation campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes COVID-19, in response to the ongoing pandemic in the country. As of late July, the Sinopharm BIBP vaccine accounted for 78% of the total 13.8 million vaccines obtained by Sri Lanka to date. The United States donated over 1.5 million Moderna vaccine through COVAX. (en)
- 斯里兰卡进行的COVID-19疫苗接种是针对严重急性呼吸系统综合症冠状病毒2（SARS-CoV-2），即引起2019年冠状病毒病（COVID-19）的病毒的持续免疫运动，以应对该国正在发生的大流行病。 (zh)
|
| dbo:thumbnail
| |
| dbo:wikiPageID
| |
| dbo:wikiPageLength
|
- 11983 (xsd:nonNegativeInteger)
|
| dbo:wikiPageRevisionID
| |
| dbo:wikiPageWikiLink
| |
| dbp:caption
|
- A Sri Lankan woman is vaccinated in 2021 as part of the COVAX initiative (en)
|
| dbp:cause
| |
| dbp:date
| |
| dbp:location
| |
| dbp:organizers
| |
| dbp:outcome
|
- * 56.4% of the Sri Lankan population has received at least one dose
* 31.5% of Sri Lankan population has received both doses (en)
|
| dbp:title
|
- COVID-19 vaccination in Sri Lanka (en)
|
| dbp:wikiPageUsesTemplate
| |
| dcterms:subject
| |
| rdfs:comment
|
- COVID-19 vaccination in Sri Lanka is an ongoing immunisation campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes COVID-19, in response to the ongoing pandemic in the country. As of late July, the Sinopharm BIBP vaccine accounted for 78% of the total 13.8 million vaccines obtained by Sri Lanka to date. The United States donated over 1.5 million Moderna vaccine through COVAX. (en)
- 斯里兰卡进行的COVID-19疫苗接种是针对严重急性呼吸系统综合症冠状病毒2（SARS-CoV-2），即引起2019年冠状病毒病（COVID-19）的病毒的持续免疫运动，以应对该国正在发生的大流行病。 (zh)
|
| rdfs:label
|
- COVID-19 vaccination in Sri Lanka (en)
- 斯里蘭卡2019冠狀病毒病疫苗接種計劃 (zh)
|
| owl:sameAs
| |
| prov:wasDerivedFrom
| |
| foaf:depiction
| |
| foaf:isPrimaryTopicOf
| |
| is dbo:wikiPageWikiLink
of | |
| is foaf:primaryTopic
of | |
.jpg?width=300)
.jpg){kind=link}